Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1995 3
1996 4
1998 4
1999 2
2000 5
2001 2
2002 1
2004 3
2005 2
2006 1
2007 2
2008 4
2009 4
2010 5
2011 5
2012 2
2013 2
2014 4
2015 3
2016 5
2017 3
2018 7
2019 8
2020 10
2021 13
2022 15
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: urushitani m. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
Amoebic encephalitis mimicking acute disseminated encephalomyelitis.
Otowa Y, Yamakawa I, Ogawa N, Kitamura A, Kim H, Sanada M, Urushitani M. Otowa Y, et al. Among authors: urushitani m. Pract Neurol. 2021 Oct;21(5):433-434. doi: 10.1136/practneurol-2021-002931. Epub 2021 Apr 29. Pract Neurol. 2021. PMID: 33927059 No abstract available.
[Immunotherapy Against Misfolded Proteins in ALS].
Urushitani M, Tamaki Y, Hikiami R, Minamiyama S. Urushitani M, et al. Brain Nerve. 2019 Nov;71(11):1289-1301. doi: 10.11477/mf.1416201439. Brain Nerve. 2019. PMID: 31722315 Japanese.
The necessity to improve disaster preparedness among patients with amyotrophic lateral sclerosis and their families.
Hirayama T, Shibukawa M, Morioka H, Hozumi M, Tsuda H, Atsuta N, Izumi Y, Nakayama Y, Shimizu T, Inoue H, Urushitani M, Yamanaka K, Aoki M, Ebihara S, Takeda A, Kano O. Hirayama T, et al. Among authors: urushitani m. J Clin Neurosci. 2023 Oct;116:87-92. doi: 10.1016/j.jocn.2023.08.002. Epub 2023 Aug 31. J Clin Neurosci. 2023. PMID: 37659173
Efficacy of oligodendrocyte precursor cells as delivery vehicles for single-chain variable fragment to misfolded SOD1 in ALS rat model.
Minamiyama S, Sakai M, Yamaguchi Y, Kusui M, Wada H, Hikiami R, Tamaki Y, Asada-Utsugi M, Shodai A, Makino A, Fujiwara N, Ayaki T, Maki T, Warita H, Aoki M, Tomonaga K, Takahashi R, Urushitani M. Minamiyama S, et al. Among authors: urushitani m. Mol Ther Methods Clin Dev. 2023 Feb 4;28:312-329. doi: 10.1016/j.omtm.2023.01.008. eCollection 2023 Mar 9. Mol Ther Methods Clin Dev. 2023. PMID: 36874245 Free PMC article.
116 results